Back

What´s needed for diagnosis and risk stratification?

18 June 2017 (11:45 - 12:07)
Organised by:
Congress Presentation Part of: The multiple facets of arrythmogenic ventricular cardiomyopathy Molecular biology / genetics EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Firat Duru

University Heart Center, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
The role of genetics for probands patients and family members.
Professor R. Hauer (Utrecht, NL)
Slides Video
Presentation thumbnail
Molecular pathogenesis of ARVC.
Doctor A. Asimaki (London, GB)
Slides Video
Presentation thumbnail
Current therapeutic concepts - A summary of the 2015 international task force consensus statement.
Professor D. Corrado (Padova, IT)
Slides Video

Access the full session

Session thumbnail
The multiple facets of arrythmogenic ventricular cardiomyopathy

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 11:45 CET
You may be interested in
thumbnail
Congress Presentation
Risk stratification of sudden cardiac death in subjects with asymptomatic ventricular preexcitation: diagnostic value of non-invasive and invasive methods
27 August 2022
thumbnail
Congress Session
HFpEF: modern approaches to diagnosis and management
17 May 2025
thumbnail
Congress Presentation
Do the variables that the clinical cardiologist looks at when requesting a genetic study in the study of idiopathic dilated cardiomyopathy have predictive value?
29 June 2021
thumbnail
Congress Presentation
Cardiovascular risk stratification in cancer survivors: time for a better approach?
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources